scholarly article | Q13442814 |
P50 | author | Geoffrey Lilley Smith | Q5069186 |
Carlos Maluquer de Motes | Q42150779 | ||
P2093 | author name string | Andrew G Bowie | |
Daniel S Mansur | |||
Hongwei Ren | |||
Leonie Unterholzner | |||
Rebecca P Sumner | |||
Brian J Ferguson | |||
Pavla Strnadova | |||
P2860 | cites work | Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism | Q21090517 |
A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes | Q24299311 | ||
Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase | Q24304123 | ||
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein | Q24305049 | ||
Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase | Q24306203 | ||
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14 | Q24312867 | ||
Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation | Q24315019 | ||
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7 | Q24338222 | ||
Vaccinia Virus Proteins A52 and B14 Share a Bcl-2–Like Fold but Have Evolved to Inhibit NF-κB rather than Apoptosis | Q27651621 | ||
Inhibition of Apoptosis and NF-κB Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence | Q27676390 | ||
betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. | Q28118570 | ||
Approaching the asymptote: 20 years later | Q28249107 | ||
A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif | Q28276184 | ||
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway | Q28615591 | ||
Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. | Q54381288 | ||
Vaccinia virus immune evasion | Q73992874 | ||
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence | Q40717481 | ||
The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. | Q40816820 | ||
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB. | Q41763836 | ||
Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus | Q42600414 | ||
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus | Q42601218 | ||
Deletion of 55 open reading frames from the termini of vaccinia virus | Q42626327 | ||
Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase | Q42631679 | ||
Structure of vaccinia virus late promoters | Q43610128 | ||
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae | Q43646853 | ||
Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route | Q45110748 | ||
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes | Q45731710 | ||
Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. | Q45749099 | ||
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity | Q45785576 | ||
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection | Q45872018 | ||
HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin | Q47965199 | ||
Shared principles in NF-kappaB signaling | Q29547234 | ||
SCF and Cullin/Ring H2-based ubiquitin ligases | Q29547637 | ||
Multiple sequence alignment with Clustal X | Q29547758 | ||
Genome sequence diversity and clues to the evolution of variola (smallpox) virus | Q30230463 | ||
Repulsion of superinfecting virions: a mechanism for rapid virus spread | Q30594313 | ||
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence | Q33910501 | ||
IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA | Q34029053 | ||
The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
Poxviruses and immune evasion | Q34172411 | ||
Poxvirus genomes: a phylogenetic analysis | Q34289377 | ||
A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. | Q34485252 | ||
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation. | Q34641590 | ||
Regulation of adaptive immunity by the innate immune system | Q34659642 | ||
Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. | Q35024097 | ||
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications | Q35804580 | ||
Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents | Q35938171 | ||
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection | Q36370370 | ||
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense | Q36370571 | ||
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence | Q36403362 | ||
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity | Q36464830 | ||
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. | Q36523222 | ||
Transient dominant selection of recombinant vaccinia viruses. | Q36808769 | ||
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes | Q36890933 | ||
The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation | Q37010771 | ||
Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways | Q37232811 | ||
A mechanism for the inhibition of fever by a virus | Q37307863 | ||
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. | Q37421291 | ||
Targeting of immune signalling networks by bacterial pathogens | Q37464760 | ||
The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
How vaccinia virus has evolved to subvert the host immune response. | Q37855047 | ||
Regulation of NF-κB by ubiquitination and degradation of the IκBs | Q37995680 | ||
β-TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/tetherin. | Q38004561 | ||
Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. | Q39697230 | ||
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor | Q40280952 | ||
Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping | Q40537769 | ||
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors | Q40542008 | ||
Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation. | Q40629419 | ||
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model | Q40695890 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P921 | main subject | NF-κB | Q411114 |
evasion of host immune response | Q1660157 | ||
P304 | page(s) | e1003183 | |
P577 | publication date | 2013-02-28 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence | |
P478 | volume | 9 |
Q47546907 | A comparison of the effect of molluscum contagiosum virus MC159 and MC160 proteins on vaccinia virus virulence in intranasal and intradermal infection routes |
Q35008790 | A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus |
Q59351861 | A novel class of viral Ankyrin proteins targeting the host E3 ubiquitin ligase Cullin-2 |
Q40090682 | A parapoxviral virion protein inhibits NF-κB signaling early in infection |
Q47289904 | A parapoxviral virion protein targets the retinoblastoma protein to inhibit NF-κB signaling |
Q38733975 | Advances in Antiviral Therapies Targeting Toll-like Receptors |
Q38968870 | Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection |
Q89621198 | Cullin-5 Adaptor SPSB1 Controls NF-κB Activation Downstream of Multiple Signaling Pathways |
Q59351050 | DNA-PK Is Targeted by Multiple Vaccinia Virus Proteins to Inhibit DNA Sensing |
Q40207067 | Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity |
Q35549043 | Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins |
Q40235609 | Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response. |
Q40213403 | Down the rabbit hole: Is necroptosis truly an innate response to infection? |
Q34047542 | EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence |
Q38954768 | Ectromelia virus encodes a family of Ankyrin/F-box proteins that regulate NFκB. |
Q35512353 | Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor. |
Q35105647 | Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling |
Q59354902 | Human Adenoviruses, Cholesterol Trafficking, and NF-κB Signaling |
Q26749801 | Inflammatory and oxidative stress in rotavirus infection |
Q35763016 | Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence. |
Q89889589 | Leaky scanning translation generates a second A49 protein that contributes to vaccinia virus virulence |
Q35108874 | Microbial strategies for antagonizing Toll-like-receptor signal transduction |
Q57009346 | Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus |
Q42314995 | Molecular mimicry: good artists copy, great artists steal |
Q38703178 | Molluscum Contagiosum Virus MC159 Abrogates cIAP1-NEMO Interactions and Inhibits NEMO Polyubiquitination. |
Q37296099 | Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation |
Q64092200 | NF-κB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-κB activation |
Q35212666 | NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses. |
Q38907450 | NSP1 of human rotaviruses commonly inhibits NF-κB signalling by inducing β-TrCP degradation |
Q37672913 | Pathogens hijack the epigenome: a new twist on host-pathogen interactions. |
Q37333716 | Poxviral protein A52 stimulates p38 mitogen-activated protein kinase (MAPK) activation by causing tumor necrosis factor receptor-associated factor 6 (TRAF6) self-association leading to transforming growth factor β-activated kinase 1 (TAK1) recruitme |
Q40090965 | Poxviruses Utilize Multiple Strategies to Inhibit Apoptosis |
Q35072342 | Putative E3 ubiquitin ligase of human rotavirus inhibits NF-κB activation by using molecular mimicry to target β-TrCP. |
Q28082629 | Recent advances on viral manipulation of NF-κB signaling pathway |
Q40066025 | Rotavirus NSP1 Requires Casein Kinase II-Mediated Phosphorylation for Hijacking of Cullin-RING Ligases |
Q37123575 | Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain |
Q37547591 | Rotavirus NSP1 protein inhibits interferon-mediated STAT1 activation |
Q38916023 | Rotavirus Strategies Against the Innate Antiviral System |
Q34100910 | SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination |
Q56987882 | Suppression of NF-κB Activity: A Viral Immune Evasion Mechanism |
Q92662243 | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms |
Q35913878 | The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation |
Q27011462 | Toll-like receptors in antiviral innate immunity |
Q59349302 | Upsetting the Balance: When Viruses Manipulate Cell Polarity Control |
Q91983844 | Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8+ T-Cell Memory |
Q36210308 | Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2 |
Q38326055 | Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. |
Q45325861 | Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase β-TrCP. |
Q30370948 | Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family |
Q37109669 | Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence |
Q38986293 | Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues |
Q26783655 | Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways |
Q52680807 | Virulent poxviruses inhibit DNA sensing by preventing STING activation. |